Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary approaches.

Recent evidence has associated the aberrant, proximal re-expression of various cell cycle control elements with neuronal cell vulnerability in Alzheimer's and Parkinson's diseases, as a common chronic neurodegeneration. This phenomenon associated with oncogenic transduction pathway activation has attracted the interest of scientists all over the world for a few years now. The purpose of this paper is to outline areas of research related to oncogenic factors or medicines in the context of potential applications for future treatment of the above mentioned chronic and, largely, incurable diseases.

[1]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Jie Shen,et al.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.

[3]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[4]  D. Tao,et al.  Neural cell cycle dysregulation and central nervous system diseases , 2009, Progress in Neurobiology.

[5]  Tak W. Mak,et al.  Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.

[6]  M. Mattson,et al.  Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease , 1998, Journal of neurochemistry.

[7]  M. Hande,et al.  A role for Brca1 in chromosome end maintenance. , 2006, Human molecular genetics.

[8]  Hyoung-Gon Lee,et al.  Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. , 2007, Biochimica et biophysica acta.

[9]  L. Tsai,et al.  p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β In Vivo , 2006, The Journal of Neuroscience.

[10]  R. Burke,et al.  Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease , 2006, Proceedings of the National Academy of Sciences.

[11]  M. Beal,et al.  Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Xiantao Wang,et al.  Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection* , 2002, The Journal of Biological Chemistry.

[13]  W. Wurst,et al.  Structural Determinants of the C-terminal Helix-Kink-Helix Motif Essential for Protein Stability and Survival Promoting Activity of DJ-1* , 2007, Journal of Biological Chemistry.

[14]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[15]  D. Lindholm,et al.  Tumor suppressor gene BRCA‐1 is expressed by embryonic and adult neural stem cells and involved in cell proliferation , 2003, Journal of neuroscience research.

[16]  Tomoya Kinumi,et al.  Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. , 2004, Biochemical and biophysical research communications.

[17]  Yufei Wang,et al.  Neuronal binucleation in Alzheimer disease hippocampus , 2008, Neuropathology and applied neurobiology.

[18]  Xin Zhao,et al.  Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert B. Petersen,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[20]  G S Taylor,et al.  PTEN and myotubularin: novel phosphoinositide phosphatases. , 2001, Annual review of biochemistry.

[21]  David S. Park,et al.  Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.

[22]  Douglas R. McDonald,et al.  β-Amyloid Fibrils Activate Parallel Mitogen-Activated Protein Kinase Pathways in Microglia and THP1 Monocytes , 1998, The Journal of Neuroscience.

[23]  T. Mitsui,et al.  Parkin enhances mitochondrial biogenesis in proliferating cells. , 2006, Human molecular genetics.

[24]  P. Calabresi,et al.  Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase , 2006, Neurobiology of Disease.

[25]  M. D'Angelo,et al.  Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells , 2009, Cell.

[26]  A. Brice,et al.  A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signalling , 2006, Nature Cell Biology.

[27]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[28]  P. Heutink,et al.  Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6 , 2010, Cell Death and Differentiation.

[29]  T. Hortobágyi,et al.  Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the Presenilin-1 Alzheimer's disease brain , 2008, Cell cycle.

[30]  Á. Almeida,et al.  Inhibition of PTEN by peroxynitrite activates the phosphoinositide‐3‐kinase/Akt neuroprotective signaling pathway , 2007, Journal of neurochemistry.

[31]  Xiongwei Zhu,et al.  Cyclin' toward dementia , 2000, Journal of neuroscience research.

[32]  Anupama E. Gururaj,et al.  p21-activated kinases in cancer , 2006, Nature Reviews Cancer.

[33]  R. Sékaly,et al.  Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. , 1993, Journal of immunology.

[34]  T. Chan,et al.  Genetic determinants at the interface of cancer and neurodegenerative disease , 2010, Oncogene.

[35]  P. Greengard,et al.  Cell cycle‐dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. , 1994, The EMBO journal.

[36]  Maria K. Lehtinen,et al.  Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. , 2002, Molecular cell.

[37]  Hyoung-Gon Lee,et al.  BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease , 2007, International journal of medical sciences.

[38]  George Perry,et al.  Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.

[39]  Jack Woods,et al.  The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. , 2007, Biochimica et biophysica acta.

[40]  U. Stochaj,et al.  Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. , 2009, Molecular biology of the cell.

[41]  Peter Davies,et al.  Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice , 2007, The Journal of Neuroscience.

[42]  S. Ackerman,et al.  Oxidative stress, cell cycle, and neurodegeneration. , 2003, The Journal of clinical investigation.

[43]  H. Zoghbi,et al.  Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.

[44]  David S. Park,et al.  DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses , 2009, Proceedings of the National Academy of Sciences.

[45]  Old Nuclei Spring New Leaks , 2009, Cell.

[46]  M. Blasco,et al.  Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy? , 2006, Alzheimer's & Dementia.

[47]  T. Mak,et al.  Tumours and tremors: how PTEN regulation underlies both , 2006, British Journal of Cancer.

[48]  Hyoung-Gon Lee,et al.  Review: Cell cycle aberrations and neurodegeneration , 2010, Neuropathology and applied neurobiology.

[49]  B. Winblad,et al.  PTEN levels in Alzheimer's disease medial temporal cortex , 2006, Neurochemistry International.

[50]  Kazuyuki Takata,et al.  PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson’s disease rat model , 2006, Neurobiology of Disease.

[51]  M. Block,et al.  Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model , 2008, The Journal of Neuroscience.

[52]  Y. Yanagawa,et al.  The p21-activated kinase is required for neuronal migration in the cerebral cortex. , 2009, Cerebral cortex.

[53]  Jinsong Meng,et al.  Abnormal Long-Lasting Synaptic Plasticity and Cognition in Mice Lacking the Mental Retardation Gene Pak3 , 2005, The Journal of Neuroscience.

[54]  O. Bandmann,et al.  p53‐dependent neuronal cell death in a DJ‐1‐deficient zebrafish model of Parkinson's disease , 2006, Journal of neurochemistry.

[55]  Douglas R. Porter,et al.  DJ-1 Transcriptionally Up-regulates the Human Tyrosine Hydroxylase by Inhibiting the Sumoylation of Pyrimidine Tract-binding Protein-associated Splicing Factor* , 2006, Journal of Biological Chemistry.

[56]  Mark A. Wilson,et al.  The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein , 2006 .

[57]  Xiongwei Zhu,et al.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. , 2008, The American journal of pathology.

[58]  B. Ahlemeyer,et al.  PTEN: A crucial mediator of mitochondria-dependent apoptosis , 2006, Apoptosis.

[59]  Xiongwei Zhu,et al.  Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.

[60]  P. Hof,et al.  Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.

[61]  Kexiang Xu,et al.  Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging , 2006, Proceedings of the National Academy of Sciences.

[62]  R. Ravid,et al.  Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology , 2005, Journal of neurochemistry.

[63]  T. Mak,et al.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 , 2006, Proceedings of the National Academy of Sciences.

[64]  David S. Park,et al.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.